Sermorelin and TB-500 (Ac-LKKTETQ) Interaction
Sermorelin and TB-500 (Ac-LKKTETQ) have a synergistic interaction with 47% confidence. Sermorelin and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. These compounds primarily affect different organ systems.
Compound Profiles
Sermorelin
GHRH Analog | Growth Hormone Releasing Hormone
Subcutaneous injection provides optimal bioavailability for binding GHRH receptors, stimulating pulsatile GH release while maintaining hypothalamic-pituitary axis integrity and allowing natural somatostatin negative feedback..
View full profileTB-500 (Ac-LKKTETQ)
Thymosin Beta-4 Active Fragment | Healing Peptide
TB-500 contains the LKKTETQ sequence which is the actin-binding motif of full-length thymosin beta-4. This fragment shares many properties of the parent protein regarding cell proliferation, differentiation, and migration.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Sermorelin with TB-500 (Ac-LKKTETQ)?
Yes, Sermorelin and TB-500 (Ac-LKKTETQ) can generally be taken together. Sermorelin and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols.
Is Sermorelin and TB-500 (Ac-LKKTETQ) safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between Sermorelin and TB-500 (Ac-LKKTETQ)?
Sermorelin and TB-500 (Ac-LKKTETQ) work through complementary pathways. Growth hormone signaling supports tissue repair processes. A well-established combination in recovery protocols. This assessment has 47% confidence and is inferred from pharmacological mechanism analysis.
How should I time Sermorelin and TB-500 (Ac-LKKTETQ)?
Sermorelin has a half-life of 10-12 minutes and TB-500 (Ac-LKKTETQ) has a half-life of Not precisely established; effects persist longer than 24 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.